Imperial College London

ProfessorEricAboagye

Faculty of MedicineDepartment of Surgery & Cancer

Professor
 
 
 
//

Contact

 

+44 (0)20 3313 3759eric.aboagye

 
 
//

Assistant

 

Mrs Maureen Francis +44 (0)20 7594 2793

 
//

Location

 

GN1Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Sharma:2019,
author = {Sharma, R and Valls, PO and Inglese, M and Dubash, S and Chen, M and Gabra, H and Montes, A and Challapalli, A and Arshad, M and Thakaran, G and Chambers, E and Cole, T and Lozano-Kuehne, J and Barwick, TD and Aboagye, EO},
pages = {S223--S223},
publisher = {SPRINGER},
title = {[F-18]fluciclatide Pet As A Biomarker Of Response To Combination Therapy Of Pazopanib And Paclitaxel In Platinum-resistant/refractory Ovarian Cancer},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000492444402024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Sharma,R
AU - Valls,PO
AU - Inglese,M
AU - Dubash,S
AU - Chen,M
AU - Gabra,H
AU - Montes,A
AU - Challapalli,A
AU - Arshad,M
AU - Thakaran,G
AU - Chambers,E
AU - Cole,T
AU - Lozano-Kuehne,J
AU - Barwick,TD
AU - Aboagye,EO
EP - 223
PB - SPRINGER
PY - 2019///
SN - 1619-7070
SP - 223
TI - [F-18]fluciclatide Pet As A Biomarker Of Response To Combination Therapy Of Pazopanib And Paclitaxel In Platinum-resistant/refractory Ovarian Cancer
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000492444402024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -